Danaher Corp
DHR.N- Latest Trade
- trading higher257.8USD
- Change
- 6.09
- % Change
2.42%Positive
- Day Range
- 254.89 - 258.78
- 52-Week Range
- 234.50 - 333.93
As of May 27 2022. Values delayed up to 15 minutes
- Previous Close
- 251.71
- Open
- 255.50
- Volume
- 60,135.00
- 3 Month Average Trading Volume
- 58.87
- Shares Out (Mil)
- 727.08
- Market Cap
- 182,001.90
- Forward P/E
- 24.22
- Dividend Yield
- 0.40
Key Statistics
1.875 mean rating - 24 analysts
- P/E Excl. Extra Items (TTM)
- 29.38
- Price To Sales (TTM)
- 6.01
- Price To Book (Quarterly)
- 4.16
- Price To Cash Flow (Per Share TTM)
- 21.57
- Total Debt/Total Equity (Quarterly)
- 46.98
- Long Term Debt/Equity (Quarterly)
- 46.96
- Return On Investment (TTM)
- 8.82
- Return On Equity (TTM)
- 8.02
2021 (millions USD)
About Danaher Corp
Company Information
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.
Address
2200 Pennsylvania Ave NW Ste 800wWASHINGTON, DC
20037-1731
United States
Industry
Scientific & Technical Instr.
Executive Leadership
- Steven M. Rales
- Chairman of the Board
- Rainer M. Blair
- President, Chief Executive Officer, Director
- Mitchell P. Rales
- Co-Founder, Director
- Matthew R. McGrew
- Chief Financial Officer, Executive Vice President
- Jennifer L. Honeycutt
- Executive Vice President
- Joakim Weidemanis
- Executive Vice President
- Jose-Carlos Gutierrez-Ramos
- Senior Vice President, Chief Scientific Officer
- Brian W. Ellis
- Senior Vice President, General Counsel
- Georgeann F. Couchara
- Senior Vice President - Human Resources
- William H. King
- Senior Vice President - Strategic Development
- Daniel A. Raskas
- Senior Vice President - Corporate Development
- Linda P. Hefner Filler
- Lead Independent Director
- Teri L. List-Stoll
- Independent Director
- Walter G. Lohr
- Independent Director
- Jessica L. Mega
- Independent Director
- Pardis C. Sabeti
- Independent Director
- A. Shane Sanders
- Independent Director
- John T. Schwieters
- Independent Director
- Alan G. Spoon
- Independent Director
- Raymond C. Stevens
- Independent Director
- Elias Zerhouni
- Independent Director
Latest News
- MarketsU.S. RESEARCH ROUNDUP Api Group, Apria, Zynga
Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Api Group, Apria and Zynga, on Tuesday.
- BusinessDanaher to buy Moderna supplier Aldevron for about $9.6 billion
Medical equipment maker Danaher Corp (DHR.N) said on Thursday it would buy privately held biotech company Aldevron in an all-cash deal for about $9.6 billion, snapping up a supplier to COVID-19 vaccine maker Moderna Inc (MRNA.O).
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,853.60 | 0.32%Positive |
| Copper | 775.00 | 0.47%Positive |
| Brent Crude Oil | 117.61 | 0.18%Positive |
| CBOT Soybeans | 1,727.75 | 0.07%Positive |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,106.47 | 1.20%Positive |
| Euro STOXX 50 | 3,795.98 | 1.49%Positive |
| FTSE 100 | 7,584.62 | 0.26%Positive |
| Nikkei 225 | 26,781.68 | 0.66%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes